title: Long-term follow-up (5 and 10 years) in recipients of HLA identical living related donor kidney grafts receiving continuous cyclosporine compared with azathioprine.
authors.affiliation: Transplant Service, Dalhousie University, Victoria General Hospital, Halifax, Nova Scotia, Canada.
authors.forename: A S
authors.initials: AS
authors.lastname: MacDonald
authors.forename: P
authors.initials: P
authors.lastname: Belitsky
authors.forename: H
authors.initials: H
authors.lastname: Bitter-Suermann
authors.forename: J
authors.initials: J
authors.lastname: Lawen
authors.forename: M
authors.initials: M
authors.lastname: MacSween
authors.forename: B
authors.initials: B
authors.lastname: Kiberd
authors.forename: K
authors.initials: K
authors.lastname: West
authors.forename: V C
authors.initials: VC
authors.lastname: McAlister
mesh_terms: D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D019520:Living Donors; D008297:Male; D015996:Survival Rate; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine; D001379:Azathioprine